ArticleCancer immunology, immunotherapy : CII2026

Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy.

Chiara Ciccarese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.